Abstract
A very high spatial resolution and a so far unsurpassed ability in distinguishing soft tissues characterize magnetic resonance imaging (MRI). This imaging technique has therefore become one of the most important diagnosis tools available in medicine. Insufficient contrast is nevertheless a drawback of the technique in many instances, hence the need for contrast agents. A number of such substances have been developed and enjoy widespread use in hospitals around the globe. However, there remains a need for new and more selective contrast media that would allow a better delineation of diseases thus helping the radiologist in giving a more precise diagnosis. This chapter is devoted to these new types of contrast agents and provides an overview of new ideas and their applications as they appear in the recent literature. Examples are given of new blood-pool agents mostly based on macromolecular derivatives. Linking contrast agents to antibodies or other biologically relevant macromolecules may provide a way of highlighting regions of interest. Such compounds are also discussed. Very recent examples of in vitro and in vivo contrast agents for imaging gene expression will also be presented, as this appears to be of utmost importance for assessing gene delivery and gene expression in gene therapy applications and for studying developmental stages in embryology. Finally, MRI contrast agents are presented that react to variables in their environment. Temperature, pH, ions, enzymes are just a few of the parameters that may influence the response of these so-called smart contrast agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
6 References
Bogdanov Jr A, Lewin M and Weissleder R (1999) Adv Drug Delivery Rev 37:279
Weissig V, Babich J and Torchilin V (2000) Colloids Surf, B 18:293
Caravan P, Ellison JJ, McMurry TJ and Lauffer RB (1999) Chem Rev (Washington, DC) 99:2293
Martin VV, Ralston WH, Hynes MR and Keana JF (1995) Bioconjugate Chem 6:616
Nunn AD, Liner KE and Tweedle MF (1997) Q J Nucl Med 41:155
Unger EC, Fritz T, Wu G et al. (1994) J Liposome Res 4:811
Paeuser S, Reszka R, Wagner S, Wolf KJ, Buhr HJ and Berger G (1997) Anti-Cancer Drug Des 12:125
Fossheim SL, Collet JM, Mansson S, Fahlvik AK, Muller RN and Klaveness J (1998) Invest Radiol 33:810
Woodle MC, Newman MS and Cohen JA (1994) J Drug Targeting 2:397
Basanez G, Goni FM and Alonso A (1997) FEBS Lett 411:281
Storrs RW, Troper FD, Li HY, Song CK, Sipkins DA, Kuniyoshi JK, Bednarski MD, Strauss HW, and Li KCP (1995) J Magn Reson Imaging 5:719
Kim SK, Pohost GM and Elgavish GA (1992) Bioconjugate Chem 3:20
Naevestad A, Fossheim SL and Fahlvik AK (1999) Preparation and structure-activity relationships of particulate magnetic agents. In: Thomsen HS, Muller RN and Mattrey RF (eds) Trends in contrast media. Springer-Verlag, Heidelberg, chap 16
McLachlan SJ, Morris MR, Lucas MA, Fisco RA, Eakins MN, Fowler DR, Scheetz RB and Olukotun AY (1994) J Magn Reson Imaging 4:301
Anzai Y, Prince MR, Chenevert TL, Maki JH, Londy F, London M, and McLachlan SJ (1997) J Magn Reson Imaging 7:209
Young SW, Balkus Jr KJ and Sherry AD (1995) US Patent 5429813
Young SW, Qing F, Rubin D, Balkus Jr KJ, Engel JS, Lang J, Dow WC, Mutch JD and Miller RA (1995) J Magn Reson Imaging 5:1
Balkus Jr KJ and Shi J (1996) Langmuir 12:6277
Balkus Jr KJ and Shi J (1996) J Phys Chem 100:16429
Braybrook JH and Hall LD (1991) Polym Int 26:251
Reynolds CH, Annan N, Beshah K, Huber JH, Shaber SH, Lenkinski RE and Wortman JA (2000) J Am Chem Soc 122:8940
Niemi P, Reisto T, Hemmilä I and Kormano M (1991) Invest Radiol 26:820
Rebizak R, Schaefer M and Dellacherie E (1998) Bioconjugate Chem 9:94
Cavagna F, Luchinat C, Scozzfava A and Xia Z (1994) Magn Reson Med 31:58
Toth E, Helm L, Kellar KE and Merbach AE (1999) Chem Eur J 5:1202
Ladd DL, Hollister R, Peng X, Wei D, Wu G, Delecki D, Snow RA, Toner JL, Kellar K, Vinay JE, Desay C, Raymond G, Kinter LB, Desser TS and Rubi DL (1999) Bioconjugate Chem 10:361
Vander Elst P, Maton F, Laurent S, Seghi F, Chapelle F and Muller RN (1997) Magn Reson Med 38:604
Weinmann H-J, Schuhmann-Giampieri G, Schmitt-Willich H, Vogler H, Frenzel T and Gries H (1991) Magn Reson Med 22:233
Muller RN, Radüchel B, Laurent S, Platzek J, Piérart C, Mareski P and Vander Elst P (1999) Eur J Inorg Chem 1949
Aime S, Botta M, Fasano M, Crich SG and Terreno E (1996) J Biol Inorg Chem 1:312
Parmelee DJ, Walovitch RC, Ouellet-Hillori S and Lauffer RB (1997) Invest Radiol 32:741
Wiener EC, Brechbiel MW, Brothers H, Magin RL, Gansow OA, Tomalia DA and Lauterbur PC (1994) Magn Reson Med 31:1
Wiener EC, Auteri FP, Chen JW, Brechbiel MW, Gansow OA, Schneider DS, Belford RL, Clarkson RB and Lauterbur PC (1996) J Am Chem Soc 118:7774
André JP, Toth E, Fischer H, Seelig A, Mäcke HR and Merbach AE (1999) Chem Eur J 5:2977
Aime S, Anelli PL, Botta M, Fedeli F, Grandi M, Paoli P and Uggeri F (1992) Inorg Chem 31:2422
Ranganathan RS, Fernandez ME, Kang SI, Nunn AD, Ratsep PC, Pillai KMR, Zhang X and Tweedle MF (1998) Invest Radiol 33:779
Sessler JL, Mody TD, Hemmi GW, Lynch V, Young SW and Miller RA (1993) J Am Chem Soc 115:10368
Sessler JL, Kral V, Hoehner MC, Chin KOA and Divila RM (1996) Pure Appl Chem 68:1291
Okuhata Y (1999) Adv Drug Delivery Rev 37:121
Ahrens ET, Rothbächer U, Jacobs RE and Fraser SE (1998) Proc Natl Acad Sci USA 95:8443
Aime S, Botta M, Garino E, Geninatti Crich S, Giovenzana G, Pagliarin R, Palmisano G and Sisti M (2000) Chem Eur J 6:2609
Anghileri MJ, Heidbreder M and Mathes R (1976) J Nucl Biol Med 20:79
Mehrishi JN (1969) Eur J Cancer 5:427
Yasui, K and Nakamura, Y (2000) Biol Pharm Bull 23:318
Unger EC, Totty WG, Neufeld DM, Otsuka FL, Murphy WA, Welsh MS, Connett JM and Philpott GW (1985) Invest Radiol 20:693
Anderson-Berg WT, Strand M, Lempert TE, Rosenbaum AE and Joseph PM (1986) J Nucl Med 27:829
Khaw BA, Gold HK and Goldman M (1989) US Patent 4859450
Curtet C, Bourgoin C, Bohy J, Saccavini JC, Thedrez P, Akoka S, Tellier C and Chatal JF (1988) Int J Cancer Suppl 2:2126
Curtet C, Tellier C, Bohy J, Conti ML, Saccavini JC, Thedrez P, Douillard JY, Chatal JF and Koprowski H (1986) Proc Natl Acad Sci USA 83:4277
Curtet C, Bourgoin C, Bohy J, Saccavini JC, Thedrez P, Akoka S, Tellier C and Chatal JF (1988) Int J Cancer Suppl 2:126
Kornguth SE, Turski PA, Perman WH, Schultz R, Kalinke T, Reale R and Raybaud F (1987) J Neurosurg 66:898
Shreve P and Aisen AM (1986) Magn Reson Med 3:336
Gohr-Rosenthal S, Schmitt-Willich H, Ebert W and Conrad J (1993) Invest Radiol 28:789
Curtet C, Maton F, Havet T, Slinkin M, Mishra A, Chatal JF and Muller RN (1998) Invest Radiol 33:752
Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD and Li KCP (1998) Nat Med (NY) 4:623
Anderson SA, Rader RK, Westlin WF, Null C, Jackson D, Lanza GM, Wickline SA and Kotyk JJ (2000) Magn Reson Med 44:433
Brasch R, Pham C, Shames D, Roberts T, van Dijke K, van Bruggen N, Mann J, Ostrowitzki S and Melnyk O (1997) J Magn Reson Imaging 7:68
Brooks PC, Clark RAF and Cheresh DA (1994) Science (Washington, DC) 264:569
Neeman M (2000) Cancer Metastasis Rev 19:39
Lanza GM, Wallace KD, Scott MJ, Cacheris WP, Abdenschein DR, Christy DH, Sharkey AM, Miller JG, Gaffney PJ and Wickline SA (1996) Circulation 95:3334
Bulte JWM, Hoekstra Y, Kamman RL, Magin RL, Webb AG, Briggs RW, Go KG, Hulstaert CE, Miltenyi S, The TH (1992) Magn Reson Med 25:148
Go KG, Bulte JWM, de Ley L, The TH, Kamman RL, Hulstaert CE, Blaauw EH and Ma LD (1993) Eur J Radiol 16:171
Reimer P, Weissleder R, Lee AS, Wittenberg J and Brady TJ (1990) Radiology (Oak Brook, Ill) 177:729
Weissleder R, Reimer P, Lee AS, Wittenberg J and Brady TJ (1990) Am J Roentgenol 155:1161
Vera DR, Buonocore MH, Wisner ER, Katzberg RW and Stadalnik RC (1995) Acad Radiol 2:497
Muhler A (1995) J Magn Reson Imaging 5:7
Paganelli G, Siccardi A, Malcovati M, Scassellati G and Fazio F (1992) EP Patent 496074
Paganelli G, Orecchia R, Jereczek-Fossa B, Grana C, Cremonesi M, De Braude F, Tradati N and Chinol M (1998) Eur J Nucl Med 25:1336
Paganelli G, Grana C, Chinol M (1997) Eur J Nucl Med 24:908
Scott WD, Pathare PM, Hamlin DK, Buhler KR and Vessella RL (1998) Bioconjugate Chem 9:813
Lemieux GA, Yarema KJ, Jacobs CL and Bertozzi CR (1999) J Am Chem Soc 121:4278
Schauer R (1985) Trends Biotechnol 357
Hakomori S and Zhang Y (1997) Chem Biol 4:97
Mahal LK and Bertozzi CR (1997) Chem Biol 4:415
Yarema KJ, Mahal LK, Bruehl RE, Rodriguez EC and Bertozzi CR (1998) J Biol Chem 273:31168
Hines JV, Ammar GM, Buss J and Schmallbrock P (1999) Bioconjugate Chem 10:155
Charlton J, Sennello J and Smith D (1997) Chem Biol 4:809
Young SW, Sidhu MK, Qing F, Muller HH, Neuder M, Zanassi G, Mody TD, Hemmi GW, Sessler JL, and Miller RA (1994) Invest Radiol 29:330
Yeh TC, Zhang W, Ildstad SC and Ho C (1993) Magn Reson Med 30:617
Yeh TC, Zhang W, Ildstad SC and Ho C (1995) Magn Reson Med 33:200
Schoepf U, Marecos EM, Melder RJ, Jain RK and Weissleder R (1998) BioTechniques 24:642
Dodd SJ, Williams M, Suhan JP, Williams DS, Koretsky AP and Ho C (1999) Biophys J 76:103
Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT and Weissleder R (2000) Nat Biotechnol 18:410
Moore A, Basilion JP, Chiocca EA and Weissleder R (1998) Biochim Biophys Acta 1402:239
Crichton RR (1991) Inorganic biochemistry of iron metabolism. Ellis Horwood, New York
Bulte JWM, Zhang SC, van Gelderen P, Herynek V, Jordan EK, Duncan ID and Frank JA (1999) Proc Natl Acad Sci USA 96:15256
Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H, Chiocca EA and Basilion JP (2000) Nat Med (NY) 6:351
Wunderbaldinger P, Bogdanov Jr A and Weissleder R (2000) Eur J Radiol 34:156
Högemann D, Josephson L, Weissleder R and Basilion JP (2000) Bioconjugate Chem 11:941
Kayyem JF, Kumar RM, Fraser SE and Meade TJ (1995) Chem Biol 2:615
Konda SD, Aref M, Brechbiel MW and Wiener EC (2000) Invest Radiol 35:50
Moghimi SM and Rajabi-Siahboomi AR (2000) Adv Drug Delivery Rev 41:129
Lee RJ and Huang L (1996) J Biol Chem 271:8481
Sudimack J and Lee RJ (2000) Adv Drug Delivery Rev 41:147
Wiener EC, Konda SD, Shadron A (1997) Invest Radiol 32:748
Josephson L, Tung CH, Moore A and Weissleder R (1999) Bioconjugate Chem 10:186
Vivès E, Brodin P and Lebleu B (1997) J Biol Chem 272:16010
Bhorade R, Weissleder R, Nakakoshi T, Moore A and Tung C-H (2000) Bioconjugate Chem 11:301
Bogdanov Jr A and Weissleder R (1998) Trends Biotechnol 16:5
Weissleder R, Simonova M, Bogdanova A, Bredow S, Enochs WS and Bogdanov Jr A (1997) Radiology (Oak Brook, Ill) 204:425
Aime S, Botta M, Fasano M, Terreno E, Kinchesh P, Calabi L and Paleari L (1996) Magn Reson Med 35:648
Peters RD and Henkelman RM (2000) Magn Reson Med 43:62
Fossheim SL, Il’-yasov KA, Hennig J and Bjornerud A (2000) Acad Radiol 7:1107
Gerweck LE and Seetharaman K (1996) Cancer Res 56:1194
Zhang S, Wu K and Sherry AD (1999) Angew Chem Int Ed 38:3192
Aime S, Barge A, Botta M, Howard JAK, Kataky R, Lowe MP, Moloney JM, Parker D and de Sousa AS (1999) Chem Commun (Cambridge) 1047
Mikawa M, Miwa N, Bräutigam M, Akaike T and Maruyama A (1998) Chem Lett 693
Mikawa M, Miwa N, Bräutigam M, Akaike T and Maruyama A (2000) J Biomed Mater Res 49:390
Hall J, Häner R, Aime S, Botta M, Faulkner S, Parker D and de Sousa AS (1998) New J Chem 627
Aime S, Botta M, Geninatti Crich S, Giovenzana G, Palmisano G and Sisti M (1999) Bioconjugate Chem 10:192
Aime S, Botta M, Geninatti Crich S, Giovenzana G, Palmisano G and Sisti M (1999) Chem Commun (Cambridge) 1577
Aime S, Botta M, Gianolio E and Terreno E (2000) Angew Chem Int Ed 39:747
Aime S, Ascenzi P, Comoglio E, Fasano M and Paoletti S (1995) J Am Chem Soc 117:9365
Burai L, Tóth E, Seibig S, Scopelliti R and Merbach A (2000) Chem Eur J 6:3761
Rudin M (2000) Nat Biotechnol 18:383
Anelli PL, Bertini I, Fragai M, Lattuada L, Luchinat C and Parigi G (2000) Eur J Inorg Chem 625
Ilies M, Supuran CT, Scozzafava A, Casini A, Mincione F, Menabuoni L, Caproiu MT, Maganu M and Banciu MD (2000) Bioorg Med Chem 8:2145
Maren TH (1967) Physiol Rev 47:595
Lauffer RB, McMurry TJ, Dunham SO, Scott DM, Parmelee DJ and Dumas S (1997) WO Patent 9736619
Moats RA, Fraser SE and Meade TJ (1997) Angew Chem Int Ed 36:726
Louie AY, Hüber MM, Ahrens ET, Rothbächer U, Moats R, Jacobs RE, Fraser SE and Meade TJ (2000) Nat Biotechnol 18:321
Taylor DM and Williams DR (1995) Trace elements medicine and chelation therapy. Royal Society of Chemistry, Cambridge, UK
Berridge MJ, Lipp P and Bootman MD (2000) Nat Rev Mol Cell Biol 1:11
Tsien RY (1994) Chem Eng News 72:34
Li W, Fraser SE and Meade TJ (1999) J Am Chem Soc 121:1413
Grynkiewicz G, Poenie M and Tsien RY (1985) J Biol Chem 260:3440
Tsien RY (1980) Biochemistry 19:2396
Aime S, Botta M, Fasano M and Terreno E (1993) Spectrochim Acta, Part A 49 A:1315
Comblin V, Gilsoul D, Hermann M, Humblet V, Jacques V, Mesbahi M, Sauvage C and Desreux JF (1999) Coord Chem Rev 185–186:451
Desreux JF, Jacques V, Humblet V, Hermann M, Comblin V and Tweedle MF (2000) US Patent 6056939
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Jacques, V., Desreux, J.F. (2002). New Classes of MRI Contrast Agents. In: Krause, W. (eds) Contrast Agents I. Topics in Current Chemistry, vol 221. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-45733-X_5
Download citation
DOI: https://doi.org/10.1007/3-540-45733-X_5
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-42247-1
Online ISBN: 978-3-540-45733-6
eBook Packages: Springer Book Archive